Elara maintained its “buy” rating on Kaynes Tech, but cut its price target by 30% on the stock to ₹5,365 from ₹7,670 earlier. The revised…

Brokerage firm Morgan Stanley described Lenskart as a differentiated play on changing lifestyle trends, adding that the company is relatively insulated from broader macro headwinds.

Refex Industries shares will be in the spotlight today after the stock tumbled nearly 20% on Friday amid developments related to income tax search proceedings…

MSCI’s broadest index of Asia-Pacific shares outside Japan, opens new tab was down 0.6%, led by a drop of as much as 2.7% in South…

Jefferies expects Hindustan Zinc’s Earnings per Share (EPS) to rise by 22% and 29% respectively in financial year 2026 and 2027, and by another 7%…

Corona Remedies raised ₹655.37 crore through the IPO, which was entirely an offer for sale. Since the issue comprised only an OFS, the company will…

The S&P 500’s tech sector has surged 22.5% year to date, making it the top performing sector of the broad-market index. The tech-heavy Nasdaq Composite…

Brent crude futures rose 25 cents, or ‌0.4%, ‌to $61.37 a barrel at 0055 GMT, and U.S. West Texas Intermediate crude was at $57.67 a…

Biocon Biologics, Regeneron and Bayer inked the agreement to dismiss all pending litigation, it added. The agreement now enables the company to launch Yesafili in…

Five stocks worth nearly ₹2,200 crore will become eligible to trade when their respective shareholder lock-in period ends today.